Longeveron (LGVN) Completes Enrollment of Pivotal Phase 2b Trial of Laromestrocel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/13/2026

1. SKHY
2. SPY
3. USO
4. META
5. SKHYV
6. PEP
7. DAL
8. NFLX
9. ALP
10. NVDA

Go back to Longeveron (LGVN) Completes Enrollment of Pivotal Phase 2b Trial of Laromestrocel
LOGICVISION (NASDAQ: LGVN) Delayed: 0.68 --0 (-0%)
Previous Close $0.68    52 Week High $1.62 
Open $0.68    52 Week Low $0.35 
Day High $0.68    P/E N/A 
Day Low $0.68    EPS $-0.17 
Volume 222       

(NASDAQ: LGVNR) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $ 
Open $2.45    52 Week Low $ 
Day High $0.00    P/E N/A 
Day Low $0.00    EPS $ 
Volume 23,525,480